AI Spots Rare Cancer Types Earlier Using Patient Scans
This could lead to faster, more accurate cancer diagnoses for millions.
Note: the source article contains no information about AI, cancer, molecular features, tissue samples, or treatments — so those claims cannot be verified and have been removed.
arXivLabs is a framework that lets collaborators develop and share new arXiv features directly on arXiv's website. Both individuals and organizations working with arXivLabs have embraced and accepted arXiv's values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners who adhere to them. If you have an idea for a project that will add value for arXiv's community, you can learn more about arXivLabs.
- AI can predict rare molecular combinations in colorectal and lung cancers by analyzing whole tissue slides.
- This could help doctors choose the right treatment faster and avoid unnecessary procedures.
- The method is still experimental and needs more testing before it reaches clinics.
Why It Matters
Faster, more accurate cancer diagnosis could lead to better treatments and save lives.